アラバマ州における小細胞肺がんの臨床試験
アラバマ州内の拠点で、小細胞肺がんに関する10件の研究が参加者を募集しています。
アラバマ州内の都市
公式研究テキスト（英語）
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
- Dothan Hematology & Oncology, Dothan
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07189871DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
- Infirmary Cancer Care, Mobile
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07472517A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Birmingham Hematology and Oncology Associates d/b/a Alabama Oncology /ID# 280063, Birmingham
- Usa Mitchell Cancer Institute /ID# 280198, Mobile
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07365241A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- UAB Medicine - UAB Hospital, Birmingham
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07488676A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
- Southern Cancer Center, PC, Daphne
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/11更新 · NCT06646276A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
- Southern Cancer Center, Daphne
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/17更新 · NCT06095505DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
- Infirmary Cancer Care, Mobile
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/23更新 · NCT05882058Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment
- University of Alabama at Birmingham, Birmingham
被験者募集中第2相
18歳以上 · 全性別 · 2026/05/08更新 · NCT05363280Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- University of Alabama at Birmingham, Birmingham
- University of South Alabama, Mobile
被験者募集中
18歳以上 · 全性別 · 2026/04/30更新 · NCT05297734ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。